innovation

Research on End-user Acceptability.and Long-term Impacts of HIV Cure Strategies (REALISE)

ABSTRACT Despite remarkable advances in HIV cure science, emerging cure candidates will likely involve trade-offs (e.g., incomplete eradication, monitoring burdens) and must compete with increasingly convenient long-acting ART; without early implementation guidance, even efficacious products may see limited uptake, particularly among the ~30–40% of people with HIV (PWH) in the U.S. who are not durably suppressed. We propose REALISE, a multidisciplinary program to define plausible cure profiles, quantify end-user preferences, and project population-level impact to inform product design and policy before market entry. Aim 1 conducts qualitative interviews with ~30 researchers and developers to delineate credible 10–20-year cure and long-acting treatment scenarios (eradication vs functional control, safety, monitoring, durability), yielding bounded “target product profiles.” Aim 2 elicits patient-centered preferences through a two-stage study: formative interviews (n=60; ≥50% not virally suppressed) to identify salient attributes; best-worst scaling (n=360 across Missouri, Georgia, and San Francisco) to prioritize attributes; and a discrete choice experiment (n=360) to quantify trade-offs versus alternative therapies, with latent class analysis to identify preference segments and estimate potential reach. Aim 3 integrates preference-based uptake from Aim 2 with Aim 1 efficacy and cost inputs in a mathematical model to estimate health impact, QALYs, net QALYs, and incremental cost-effectiveness across heterogeneous populations and Ending the HIV Epidemic jurisdictions. Innovation lies in linking cure R&D horizons to end-user preferences and transmission-dynamic outcomes, an approach that anticipates real-world use rather than retrofitting after approval. Deliverables include ranked cure attributes for product optimization, uptake projections including among unsuppressed PWH, and jurisdiction-specific value assessments to guide public health investment. By aligning cure design with what patients will accept and systems can sustain, REALISE will accelerate effective deployment of future cure strategies and maximize their contribution to Ending the HIV Epidemic. In doing so, this study advances NIH's priorities by connecting implementation science with prevention, treatment, and cure research. Using a multidisciplinary strategy to refine and extend `target product profiles,' REALISE will ensure cure development reflects patient needs and accelerate translation into real-world benefit.

Urothelial Resurfacing with Irreversible Electroporation for Adjuvant Therapy of Bladder Cancer

PROJECT SUMMARY Over 70% of bladder cancer (BCa) patients are diagnosed with early-stage and localized non-muscle invasive disease (NMIBC), yet achieving durable cancer-free survival remains a significant challenge. Most of these patients will experience local tumor recurrence within five years following standard of care (SoC) transurethral resection of bladder tumor (TURBT) and intravesical adjuvant chemo- or immunotherapy. Recurrence is driven by microscopic tumors and premalignant lesions dispersed within the urothelial layer that survive and escape these treatments. As TURBT effectively treats tumors visible on imaging, current research has predominantly focused on drugs and biologics for improving intravesical adjuvant therapy. In this proposal we pose the provocative question whether a TURBT-like ablative technique can be extended to debulk malignancy in the entire bladder and investigate the synergy with intravesical adjuvant therapy in improving outcomes. Our objective is to address this technology and knowledge gap by developing and validating whole bladder urothelial resurfacing (WBUR) using irreversible electroporation (IRE). During IRE, microsecond-long pulsed electric fields (PEF) are used to induce rapid cell death by catastrophic permeabilization of the cell membrane, without affecting the extracellular matrix (ECM) within the treated tissue. In prior work, we designed devices that utilized this unique mechanism of IRE for performing penetrative ablation in the ureter, bile duct and bronchus of swine while preserving lumen function. Our findings provided strong rationale for IRE being an ideal candidate for WBUR as alternate techniques such as thermal ablation or ionizing radiation must be performed with extreme care in the bladder to avoid perforation or fistula formation. In subsequent preliminary work we developed technology to demonstrate the feasibility and safety of WBUR with IRE in a rat model of BCa and scalability in human-sized swine bladder. In Aim 1, we will investigate the cancer treatment efficacy of combination WBUR and intravesical adjuvant therapy. In Aim 2, validate WBUR derived liquid biopsy for monitoring cancer status. In Aim 3, engineer PEF delivery strategy to enhance the safety and specificity of WBUR. The innovation of our proposed work is defined by developing whole bladder ablation as a debulking strategy and examining its synergy with SOC adjuvant therapy (Aim 1), enabled by new electrode paradigm and PEF delivery strategy (Aim 3), monitoring by an unconventional liquid biopsy approach (Aim 2). Our work can immediately aid the management of NMIBC patients who cannot undergo radical cystectomy, with future application as a cancer prevention strategy in high-risk patients. Success of individual aims will result in major contributions to the topics of IRE, BCa treatment and diagnosis.

Behavioral, Implementation & Community Sciences Core

PROJECT SUMMARY: BEHAVIORAL, IMPLEMENTATION, AND COMMUNITY SCIENCES (BICS) CORE Like many US jurisdictions, New York City (NYC) is not on track to achieve 2030 End the Epidemic (EHE) 95- 95-95 goals. By the end of 2023, 95% of people with HIV (PWH) in NYC had been diagnosed with HIV, but only 88% of those were in HIV care, and of those, only 80% were virally suppressed. Further, in 2022, only 40% of individuals estimated to need PrEP were prescribed it. Highly efficacious biomedical HIV treatment and prevention interventions have the potential to end the HIV epidemic, but only if they are accessed and used. Yet, behavioral, social, and structural determinants of real-world adoption as well as population-level impact of HIV prevention, care, and treatment innovations have not been addressed adequately for individuals or communities. Meeting EHE goals will depend on behavioral, implementation, and community sciences research that identifies factors contributing to these outcomes, informs interventions to address them, and ensures that communities affected by HIV are engaged throughout the research process. The Behavioral, Implementation, and Community Sciences (BICS) Core will facilitate such rigorous, innovative research by Columbia University (CU) and Weill Cornell Medicine (WCM) investigators – particularly early career investigators (ECIs) and those new to HIV research – to help achieve EHE 2030 goals. The BICS Core will support the use of relevant theories, methods, and analytic approaches to advance the integration of context-specific behavioral, implementation, and community sciences perspectives across the research continuum – from basic research through scale-up and sustainment of evidence-based interventions. The Core has three Aims: (1) Behavioral science: To support CFAR users in developing, selecting, and integrating behavioral science methodologies across the research continuum; (2) Implementation science: To support CFAR users in designing and conducting implementation studies and related health services research and (3) Community science: To facilitate rigorous community-based participatory research across the research continuum to strengthen and sustain stakeholder engagement that will optimize research translation and impact. Led by Core Co-Directors Robert Remien and Bruce Schackman and Core Associate Directors Delivette Castor, Shashi Kapadia, and Justin Knox, the BICS Core will use multiple approaches to achieve each of these aims, including substantive scientific consultations on proposed or ongoing research; access to resources and tools; and seminars and educational activities that promote integration of these methods into EHE research. The Core, thus, will support CU-WCM CFAR investigators and outside collaborators – including ECIs and investigators new to HIV research – to advance local and national EHE goals.

ATPase Chromatin Remodeling Complexes as Modulators of HIV-1 Latency and Therapeutic Targets

Abstract Significance: HIV persists in long-lived CD4⁺ T cell reservoirs despite suppressive ART, as integrated proviruses remain poised for reactivation. Chromatin remodeling is a central barrier to durable silencing, yet most studies have focused on SWI/SNF family members. The roles of non- SWI/SNF remodelers remain poorly defined, limiting our ability to rationally design host-directed “block-and-lock” cure strategies. Our unbiased shRNA screen of all 16 human remodeler ATPases identified EP400, CHD1, and CHD9 as repressors and INO80A, SMARCA5, and CHD2 as activators, establishing chromatin remodeling as a key determinant of HIV latency. Innovation: Our prior studies revealed that the p400 complex regulates HIV transcription through dual mechanisms: directly, by engaging Tat via the DMAP1 subunit to block Tat-TAR RNA interactions and restrict p-TEFb recruitment; and indirectly, by altering host transcriptional programs that control T cell activation states. Building on this mechanistic precedent and methodological platform, we now focus on INO80A, SMARCA5, CHD1, and CHD2, remodelers from distinct ATPase families that govern Tat-independent checkpoints at initiation, pause release, and elongation. Methodologically, we will apply TurboID-ChAP-MS (locus-specific proteomics), BEM-seq (single-nucleosome mapping), and degron-mediated acute depletion with ATPase-dead rescue to interrogate remodeler function with unprecedented resolution. Approach: Aim 1 will define the ATPase requirement and transcriptional checkpoints regulated by INO80A, SMARCA5, CHD1, and CHD2 using degron/CRISPR perturbations, ChIP-seq, nascent RNA profiling, and nucleosome mapping. Aim 2 will characterize remodeler-specific complexes and Tat dependence at the HIV promoter via TurboID proximity labeling integrated with chromatin affinity purification-mass spectrometry. Aim 3 will test combinatorial perturbations in Jurkat and primary CD4⁺ T cell latency models, including ART-suppressed donor cells, to identify synergistic “block-and-lock” strategies that enforce durable proviral silencing. Impact: By defining remodeler-specific mechanisms at discrete transcriptional checkpoints and leveraging their enzymatic, druggable activities, this work will establish chromatin remodeling as a therapeutic axis for durable HIV suppression and functional cure.

SUPPORT SERVICES FOR THE PREVENTION AND TREATMENT THROUGH A COMPREHENSIVE CARE CONTINUUM FOR HIV-AFFECTED ADOLESCENTS IN RESOURCE CONSTRAINED SETTINGS IMPLEMENTATION SCIENCE NETWORK

Support Services for the Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATC3H-IN) (UG1/UM2) Program The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) requires support for logistical and operational coordination, website and communication management, analytic and data management, infrastructure for emerging research, regulatory, and monitoring of research activities for the Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATC3H-IN) (UG1/UM2) Program. The NICHD and partner NIH Institutes anticipate funding 8 PATC3H-IN UG1 awards in Asia and throughout sub-Saharan Africa in 2023 through a cooperative agreement mechanism for interventions of high public health significance: The prevention of new HIV infections among adolescents at risk, and the identification of, linkage to and retention in care of, and long-term viral suppression among youth living with HIV in low-to-middle income countries with high HIV burden. The PATC3H-IN network will expand and/or improve on successes achieved by its predecessor, PATC3H, to new geographic settings and/or risk populations and stimulate much needed implementation science (IS) research in the prevention of new HIV infections among adolescents at risk and the identification of, and linkage and retention to care of and long-term viral suppression among youth living with HIV in low-to-middle income countries (LMICs). PATC3H-IN will establish a network of investigators with multidisciplinary expertise on the youth-specific PHCC and in IS research, whose mission will be to evaluate promising prevention innovations contextually and developmentally tailored for HIV uninfected at-risk youth, and treatment and care interventions for youth living with HIV which have demonstrated efficacy and/or effectiveness in adolescent or adult populations and to translate them into public health practices. The structure of PATC3H-IN will consist of multiple interdependent functional components: (1) Five Clinical Research Centers (CRC) awarded through the UG1 grant mechanism; (2) one Implementation Science Coordinating Center (ISCC) to be awarded through a UM2 grant mechanism in 2024; and (3) a Scientific Leadership Committee (SLC). The CRCs will conduct clinical research and clinical trials, including implementation, effectiveness, and hybrid implementation-effectiveness studies at their 8-or more participating Clinical Research Performance Sites (CRPS). The ISCC will establish infrastructure to support research education and capacity building across PATC3H-IN, as well as infrastructure for stakeholder engagement in and dissemination of findings from PATC3H-IN and advanced statistical modeling support across PATC3H-IN. The ISCC will also provide infrastructure for conducting foundational research to support the work of clinical sites, including possible modeling studies and translation projects, as well as national surveys, and/or systematic collection and analysis of relevant policies and laws. Lastly, the SLC will be responsible for PATC3H-IN governance, oversight, and coordination, and will develop and implement the network research agenda, convening working groups as needed, prioritizing emerging research projects, efficiently managing the development of clinical protocols, implementing and completing clinical trials, and ensuring timely publication and communication of results.

Post-diagnosis changes in body composition and renal cell cancer survival

ABSTRACT Significance. Clear cell renal cell carcinoma (ccRCC) is the most common form of kidney cancer and most lethal subtype, and there is great interest in the identification of potentially modifiable prognostic factors. Although weight status seems to be relevant, the relationship between body mass index (BMI) at diagnosis and survival among ccRCC patients indicates that mortality is lowest among those classified as overweight or obese at the time of diagnosis by BMI. This has resulted in confusion in clinical guidance for weight management among ccRCC patients. Recent work involving body composition features (adipose and muscle tissue) has provided some insight, but we do not understand how weight or body composition changes after diagnosis relate to survival, nor how these changes relate to pathological and molecular tumor features— information which is needed to resolve this controversy. Rigorous analytical approaches are further required to accurately address these questions. Innovation. Our study is highly innovative in that 1) we will be the first to leverage a large-scale cohort of ccRCC patients with multiple assessments of weight and body composition from diagnosis onward; 2) we will examine tumor characteristics, including molecular features, as potential drivers of these changes; and 3) we will use a rigorous joint modeling approach to simultaneously model the post-diagnosis trajectories of weight and body composition and their relationships with cancer outcomes in the most statistically sound manner. Our findings will inform clinical management of, and identify modifiable body composition features to improve survival for the growing number of ccRCC patients. Approach. We will use available data from the RESOLVE cohort, an NCI-funded retrospective cohort of 1,239 Stage I-III clear-cell renal cell carcinoma (ccRCC) patients diagnosed between 2000-2020 at Memorial Sloan Kettering Cancer Center. These data include clinical and patient-level factors collected from the medical record, including repeated height and weight assessments, body composition measures from existing computed tomography scans, pathological and molecular tumor characteristics, and overall survival (OS) and disease-free survival (DFS). We will use a joint modeling approach to simultaneously model changes in post-diagnosis body weight (Aim 1) and OS and DFS, as well as post-diagnosis changes in muscle and adipose tissue features (Aim 2) and OS and DFS. Models will include molecular tumor characteristics as predictors of these longitudinal trajectories. Impact. These results will provide crucial insight into the relationship between body composition changes and outcomes among ccRCC patients, and potentially identify tumor-related characteristics driving these associations. These results will resolve apparent paradoxes around the relationship between obesity and ccRCC mortality and identify potential targets for nutrition and physical activity interventions on body composition.

Glycoengineering core a(1,3)-fucose motifs to enhance HIV-1 envelope vaccine immunogenicity

Project Summary The HIV-1 envelope glycoprotein (Env) is the sole target of neutralizing antibodies (NAbs). We previously developed a vaccine platform integrating three innovations: (1) the uncleaved prefusion-optimized (UFO) trimer design to stabilize Env; (2) multilayered single-component self-assembling protein nanoparticles (1c-SApNPs) for multivalent trimer display; and (3) enzymatic trimming of oligomannose glycans on CHO cell-produced Env immunogens. Glycan trimming substantially improved Env immunogenicity by enhancing tier 2 NAb elicitation, reducing off-target responses to immunodominant glycan sites, and increasing responder rates. These vaccine candidates are now in phase 1 clinical trials (NCT06541093; NCT06905275). Building on this foundation, we propose a novel strategy to enhance immunogenicity by incorporating core α(1,3)-fucose into HIV-1 Env. Core α(1,3)-fucose, a key allergenic epitope in many plant and insect glycoproteins, is highly immunogenic in humans and other mammals. Our central hypothesis is that the targeted introduction of core α(1,3)-fucose will convert the glycan shield from an immune-evasive barrier into an immunogenic trigger that promotes NAb induction. Glycoengineered cell lines expressing α(1,3)-fucose will enable production of highly immunogenic Env vaccines suitable for preclinical and clinical testing. Importantly, particulate display of these Env trimers on 1c-SApNPs can suppress IgE-mediated allergic pathways by inducing high-affinity protective IgGs, ensuring vaccine safety. Aim 1 will focus on producing core α(1,3)-fucosylated HIV-1 Env immunogens. We will begin by developing a transient insect cell expression system using BTI-TN-5B1-4 (“High Five” or Hi5) cells to produce Env with short paucimannose glycans bearing native α(1,3)-fucose. To further enhance α(1,3)-fucosylation, we will co-express exogenous core α(1,3)-fucosyltransferases in insect and CHO cells. We will validate glycan profiles and characterize the biochemical, biophysical, structural, and antigenic properties of the resulting immunogens. Aim 2 will assess the immunogenicity of these glycoengineered HIV-1 Env immunogens. Using our previously established glycan-trimmed Env immunogens as benchmarks, we will immunize mice, rabbits, and nonhuman primates (NHPs). Mice will be used for early-stage immunogen and adjuvant screening; rabbits to evaluate glycan hole-targeting NAb responses; and key vaccine formulations will advance to NHP studies. We will assess autologous and heterologous tier 2 NAb responses and vaccine responder rates. Aim 3 will elucidate the functional, structural, repertoire, and mechanistic basis of vaccine-induced immunity. We will isolate NAbs via Env-specific single-cell sorting and antibody cloning, map epitopes by electron microscopy (EM) and X-ray crystallography, perform next-generation sequencing (NGS) of B-cell repertoires, and trace NAb lineages. Finally, we will investigate antigen trafficking, retention, presentation, and germinal center (GC) reactions in lymph nodes. Together, these studies will define a new class of glycoengineered HIV-1 vaccines and establish core α(1,3)-fucose as a novel immunomodulatory tool to overcome glycan shield-mediated immune evasion.

Adventures in Spin Labeling: Clinical Perfusion Imaging and the Path to Technical Innovation

Arterial spin labeling (ASL) MRI has become a vital tool in clinical neuroimaging, enabling noninvasive assessment of cerebral perfusion across a range of conditions including stroke, vascular malformations, and brain tumors. With broader clinical adoption, its practical strengths — as well as important limitations — have become increasingly clear.

Understanding reward-guided learning using large-scale datasets

Understanding the neural mechanisms of reward-guided learning is a long-standing goal of computational neuroscience. Recent methodological innovations enable us to collect ever larger neural and behavioral datasets. This presents opportunities to achieve greater understanding of learning in the brain at scale, as well as methodological challenges. In the first part of the talk, I will discuss our recent insights into the mechanisms by which zebra finch songbirds learn to sing. Dopamine has been long thought to guide reward-based trial-and-error learning by encoding reward prediction errors. However, it is unknown whether the learning of natural behaviours, such as developmental vocal learning, occurs through dopamine-based reinforcement. Longitudinal recordings of dopamine and bird songs reveal that dopamine activity is indeed consistent with encoding a reward prediction error during naturalistic learning. In the second part of the talk, I will talk about recent work we are doing at DeepMind to develop tools for automatically discovering interpretable models of behavior directly from animal choice data. Our method, dubbed CogFunSearch, uses LLMs within an evolutionary search process in order to "discover" novel models in the form of Python programs that excel at accurately predicting animal behavior during reward-guided learning. The discovered programs reveal novel patterns of learning and choice behavior that update our understanding of how the brain solves reinforcement learning problems.

Understanding reward-guided learning using large-scale datasets

Understanding the neural mechanisms of reward-guided learning is a long-standing goal of computational neuroscience. Recent methodological innovations enable us to collect ever larger neural and behavioral datasets. This presents opportunities to achieve greater understanding of learning in the brain at scale, as well as methodological challenges. In the first part of the talk, I will discuss our recent insights into the mechanisms by which zebra finch songbirds learn to sing. Dopamine has been long thought to guide reward-based trial-and-error learning by encoding reward prediction errors. However, it is unknown whether the learning of natural behaviours, such as developmental vocal learning, occurs through dopamine-based reinforcement. Longitudinal recordings of dopamine and bird songs reveal that dopamine activity is indeed consistent with encoding a reward prediction error during naturalistic learning. In the second part of the talk, I will talk about recent work we are doing at DeepMind to develop tools for automatically discovering interpretable models of behavior directly from animal choice data. Our method, dubbed CogFunSearch, uses LLMs within an evolutionary search process in order to "discover" novel models in the form of Python programs that excel at accurately predicting animal behavior during reward-guided learning. The discovered programs reveal novel patterns of learning and choice behavior that update our understanding of how the brain solves reinforcement learning problems.

Brain-Wide Compositionality and Learning Dynamics in Biological Agents

Biological agents continually reconcile the internal states of their brain circuits with incoming sensory and environmental evidence to evaluate when and how to act. The brains of biological agents, including animals and humans, exploit many evolutionary innovations, chiefly modularity—observable at the level of anatomically-defined brain regions, cortical layers, and cell types among others—that can be repurposed in a compositional manner to endow the animal with a highly flexible behavioral repertoire. Accordingly, their behaviors show their own modularity, yet such behavioral modules seldom correspond directly to traditional notions of modularity in brains. It remains unclear how to link neural and behavioral modularity in a compositional manner. We propose a comprehensive framework—compositional modes—to identify overarching compositionality spanning specialized submodules, such as brain regions. Our framework directly links the behavioral repertoire with distributed patterns of population activity, brain-wide, at multiple concurrent spatial and temporal scales. Using whole-brain recordings of zebrafish brains, we introduce an unsupervised pipeline based on neural network models, constrained by biological data, to reveal highly conserved compositional modes across individuals despite the naturalistic (spontaneous or task-independent) nature of their behaviors. These modes provided a scaffolding for other modes that account for the idiosyncratic behavior of each fish. We then demonstrate experimentally that compositional modes can be manipulated in a consistent manner by behavioral and pharmacological perturbations. Our results demonstrate that even natural behavior in different individuals can be decomposed and understood using a relatively small number of neurobehavioral modules—the compositional modes—and elucidate a compositional neural basis of behavior. This approach aligns with recent progress in understanding how reasoning capabilities and internal representational structures develop over the course of learning or training, offering insights into the modularity and flexibility in artificial and biological agents.

Using Adversarial Collaboration to Harness Collective Intelligence

There are many mysteries in the universe. One of the most significant, often considered the final frontier in science, is understanding how our subjective experience, or consciousness, emerges from the collective action of neurons in biological systems. While substantial progress has been made over the past decades, a unified and widely accepted explanation of the neural mechanisms underpinning consciousness remains elusive. The field is rife with theories that frequently provide contradictory explanations of the phenomenon. To accelerate progress, we have adopted a new model of science: adversarial collaboration in team science. Our goal is to test theories of consciousness in an adversarial setting. Adversarial collaboration offers a unique way to bolster creativity and rigor in scientific research by merging the expertise of teams with diverse viewpoints. Ideally, we aim to harness collective intelligence, embracing various perspectives, to expedite the uncovering of scientific truths. In this talk, I will highlight the effectiveness (and challenges) of this approach using selected case studies, showcasing its potential to counter biases, challenge traditional viewpoints, and foster innovative thought. Through the joint design of experiments, teams incorporate a competitive aspect, ensuring comprehensive exploration of problems. This method underscores the importance of structured conflict and diversity in propelling scientific advancement and innovation.

It’s All About Motion: Functional organization of the multisensory motion system at 7T

The human middle temporal complex (hMT+) has a crucial biological relevance for the processing and detection of direction and speed of motion in visual stimuli. In both humans and monkeys, it has been extensively investigated in terms of its retinotopic properties and selectivity for direction of moving stimuli; however, only in recent years there has been an increasing interest in how neurons in MT encode the speed of motion. In this talk, I will explore the proposed mechanism of speed encoding questioning whether hMT+ neuronal populations encode the stimulus speed directly, or whether they separate motion into its spatial and temporal components. I will characterize how neuronal populations in hMT+ encode the speed of moving visual stimuli using electrocorticography ECoG and 7T fMRI. I will illustrate that the neuronal populations measured in hMT+ are not directly tuned to stimulus speed, but instead encode speed through separate and independent spatial and temporal frequency tuning. Finally, I will suggest that this mechanism may play a role in evaluating multisensory responses for visual, tactile and auditory stimuli in hMT+.

Neuromatch 5

Neuromatch 5 (Neuromatch Conference 2022) was a fully virtual conference focused on computational neuroscience broadly construed, including machine learning work with explicit biological links. After four successful Neuromatch conferences, the fifth edition consolidated proven innovations from past events, featuring a series of talks hosted on Crowdcast and flash talk sessions (pre-recorded videos) with dedicated discussion times on Reddit.

Exploring the endocannabinoid system for intervention innovation in autism

Exploration-Based Approach for Computationally Supported Design-by-Analogy

Engineering designers practice design-by-analogy (DbA) during concept generation to retrieve knowledge from external sources or memory as inspiration to solve design problems. DbA is a tool for innovation that involves retrieving analogies from a source domain and transferring the knowledge to a target domain. While DbA produces innovative results, designers often come up with analogies by themselves or through serendipitous, random encounters. Computational support systems for searching analogies have been developed to facilitate DbA in systematic design practice. However, many systems have focused on a query-based approach, in which a designer inputs a keyword or a query function and is returned a set of algorithmically determined stimuli. In this presentation, a new analogical retrieval process that leverages a visual interaction technique is introduced. It enables designers to explore a space of analogies, rather than be constrained by what’s retrieved by a query-based algorithm. With an exploration-based DbA tool, designers have the potential to uncover more useful and unexpected inspiration for innovative design solutions.

The Multisensory Scaffold for Perception and Rehabilitation

The french roots of electrophysiology

This talk looks at the subject of my biography, the German physiologist Emil du Bois-Reymond (1818–1896). With respect to his philosophy of biological reduction, his methods of electrophysiological experiment, and his co-discovery of the action potential, du Bois-Reymond is generally considered one of the founders of neuroscience. Less well known are the origins of his innovation: French writers shaped his outlook on science, just as French scientists shaped his practice in the laboratory. I contend that du Bois-Reymond’s originality is the product of his synthesis of French traditions with German concerns.

From bench to clinic – Translating fundamental neuroscience into real-life healthcare practices, and developing nationally recognised life science companies

Dr. Ryan C.N. D’Arcy is a Canadian neuroscientist, researcher, innovator and entrepreneur. Dr. D'Arcy co-founded HealthTech Connex Inc. and serves as President and Chief Scientific Officer. HealthTech Connex translates neuroscience advances into health technology breakthroughs. D'Arcy is most known for coining the term "brain vital signs" and for leading the research and development of the brain vital signs framework. Dr. D’Arcy also holds a BC Leadership Chair in Medical Technology, is a full Professor at Simon Fraser University, and a member of the DM Centre for Brain Health at the University of British Columbia. He has published more than 260 academic works, attracted more than $85 Million CAD in competitive research and innovation funding, and been recognized through numerous awards and distinctions. Please join us for an exciting virtual talk with Dr. D'Arcy who will speak on some of the current research he is involved in, how he is translating this research into real-life applications, and the development of HealthTech Connects Inc.

Scaffolding up from Social Interactions: A proposal of how social interactions might shape learning across development

Social learning and analogical reasoning both provide exponential opportunities for learning. These skills have largely been studied independently, but my future research asks how combining skills across previously independent domains could add up to more than the sum of their parts. Analogical reasoning allows individuals to transfer learning between contexts and opens up infinite opportunities for innovation and knowledge creation. Its origins and development, so far, have largely been studied in purely cognitive domains. Constraining analogical development to non-social domains may mistakenly lead researchers to overlook its early roots and limit ideas about its potential scope. Building a bridge between social learning and analogy could facilitate identification of the origins of analogical reasoning and broaden its far-reaching potential. In this talk, I propose that the early emergence of social learning, its saliency, and its meaningful context for young children provides a springboard for learning. In addition to providing a strong foundation for early analogical reasoning, the social domain provides an avenue for scaling up analogies in order to learn to learn from others via increasingly complex and broad routes.

NeurotechRI Kickoff Meeting

The digital kickoff of NeurotechRI will take place on the 26th from 13:00 to 16:00 (CET). Come and join us as we discuss our plans for the Graduate School and our research and innovation roadmap! The programme can be downloaded here. Don’t miss out on our Board of Governors presentation of the project and the synergies with NeurotechEU, meet with our keynote speakers from the European Research Executive Agency: Mr Stijn Delaure (DG R&I, Unit A3 “R&I Actors and Research Careers”) and Ms Marta Truco Calbet (DG R&I, Unit C.4 "Reforming European R&I and Research Infrastructures''). Last but not least, the day will finish with a roundtable discussion organised by our students society. The roundtable will be an open space and an opportunity for all students to discuss their needs in education. Registration is open: www.crowdcast.io/e/neurotechri-kickoff

Storythinking: Why Your Brain is Creative in Ways that Computer AI Can't Ever Be

Computer AI thinks differently from us, which is why it's such a useful tool. Thanks to the ingenuity of human programmers, AI's different method of thinking has made humans redundant at certain human tasks, such as chess. Yet there are mechanical limits to how far AI can replicate the products of human thinking. In this talk, we'll trace one such limit by exploring how AI and humans create differently. Humans create by reverse-engineering tools or behaviors to accomplish new actions. AI creates by mix-and-matching pieces of preexisting structures and labeling which combos are associated with positive and negative results. This different procedure is why AI cannot (and will never) learn to innovate technology or tactics and why it also cannot (and will never) learn to generate narratives (including novels, business plans, and scientific hypotheses). It also serves as a case study in why there's no reason to believe in "general intelligence" and why computer AI would have to partner with other mechanical forms of AI (run on non-computer hardware that, as of yet, does not exist, and would require humans to invent) for AI to take over the globe.

Evolving Neural Networks

Evolution has shaped neural circuits in a very specific manner, slowly and aimlessly incorporating computational innovations that increased the chances to survive and reproduce of the newly born species. The discoveries done by the Evolutionary Developmental (Evo-Devo) biology field during the last decades have been crucial for our understanding of the gradual emergence of such innovations. In turn, Computational Neuroscience practitioners modeling the brain are becoming increasingly aware of the need to build models that incorporate these innovations to replicate the computational strategies used by the brain to solve a given task. The goal of this workshop is to bring together experts from Systems and Computational Neuroscience, Machine Learning and the Evo-Devo field to discuss if and how knowing the evolutionary history of neural circuits can help us understand the way the brain works, as well as the relative importance of learned VS innate neural mechanisms.

Brainstorms Festival

The Brainstorms Festival is the No1 online neuroscience and AI event for scientists, businesses, investors and startups. Join and listen to talks from leading scientists, take part in interactive discussions, and network with the people driving neurotech and AI innovation globally. The festival provides a digital playground for visionaries with dozens of medical innovations, panel discussions, workshops, a hackathon, and a neuroethics panel discussion which is crucial topic for neurodiversity and disability rights. Register now and be part of our amazing crowd!

Machine Learning as a tool for positive impact : case studies from climate change

Climate change is one of our generation's greatest challenges, with increasingly severe consequences on global ecosystems and populations. Machine Learning has the potential to address many important challenges in climate change, from both mitigation (reducing its extent) and adaptation (preparing for unavoidable consequences) aspects. To present the extent of these opportunities, I will describe some of the projects that I am involved in, spanning from generative model to computer vision and natural language processing. There are many opportunities for fundamental innovation in this field, advancing the state-of-the-art in Machine Learning while ensuring that this fundamental progress translates into positive real-world impact.

MidsummerBrains - computational neuroscience from my point of view

Computational neuroscience is a highly interdisciplinary field ranging from mathematics, physics and engineering to biology, medicine and psychology. Interdisciplinary collaborations have resulted in many groundbreaking innovations both in the research and application. The basis for successful collaborations is the ability to communicate across disciplines: What projects are the others working on? Which techniques and methods are they using? How is data collected, used and stored? In this webinar series, several experts describe their view on computational neuroscience in theory and application, and share experiences they had with interdisciplinary projects. This webinar is open for all interested students and researchers. If you are interested to participate live, please send a short message to smartstart@fz-juelich.de Please note, these lectures will be recorded for subsequent publishing as online lecture material.

MidsummerBrains - computational neuroscience from my point of view

Computational neuroscience is a highly interdisciplinary field ranging from mathematics, physics and engineering to biology, medicine and psychology. Interdisciplinary collaborations have resulted in many groundbreaking innovations both in the research and application. The basis for successful collaborations is the ability to communicate across disciplines: What projects are the others working on? Which techniques and methods are they using? How is data collected, used and stored? In this webinar series, several experts describe their view on computational neuroscience in theory and application, and share experiences they had with interdisciplinary projects. This webinar is open for all interested students and researchers. If you are interested to participate live, please send a short message to smartstart@fz-juelich.de Please note, these lectures will be recorded for subsequent publishing as online lecture material.

MidsummerBrains - computational neuroscience from my point of view

Computational neuroscience is a highly interdisciplinary field ranging from mathematics, physics and engineering to biology, medicine and psychology. Interdisciplinary collaborations have resulted in many groundbreaking innovations both in the research and application. The basis for successful collaborations is the ability to communicate across disciplines: What projects are the others working on? Which techniques and methods are they using? How is data collected, used and stored? In this webinar series, several experts describe their view on computational neuroscience in theory and application, and share experiences they had with interdisciplinary projects. This webinar is open for all interested students and researchers. If you are interested to participate live, please send a short message to smartstart@fz-juelich.de Please note, these lectures will be recorded for subsequent publishing as online lecture material.

MidsummerBrains - computational neuroscience from my point of view

Computational neuroscience is a highly interdisciplinary field ranging from mathematics, physics and engineering to biology, medicine and psychology. Interdisciplinary collaborations have resulted in many groundbreaking innovations both in the research and application. The basis for successful collaborations is the ability to communicate across disciplines: What projects are the others working on? Which techniques and methods are they using? How is data collected, used and stored? In this webinar series, several experts describe their view on computational neuroscience in theory and application, and share experiences they had with interdisciplinary projects. This webinar is open for all interested students and researchers. If you are interested to participate live, please send a short message to smartstart@fz-juelich.de Please note, these lectures will be recorded for subsequent publishing as online lecture material.

MidsummerBrains - computational neuroscience from my point of view

Computational neuroscience is a highly interdisciplinary field ranging from mathematics, physics and engineering to biology, medicine and psychology. Interdisciplinary collaborations have resulted in many groundbreaking innovations both in the research and application. The basis for successful collaborations is the ability to communicate across disciplines: What projects are the others working on? Which techniques and methods are they using? How is data collected, used and stored? In this webinar series, several experts describe their view on computational neuroscience in theory and application, and share experiences they had with interdisciplinary projects. This webinar is open for all interested students and researchers. If you are interested to participate live, please send a short message to smartstart@fz-juelich.de Please note, these lectures will be recorded for subsequent publishing as online lecture material.

MidsummerBrains - computational neuroscience from my point of view

Computational neuroscience is a highly interdisciplinary field ranging from mathematics, physics and engineering to biology, medicine and psychology. Interdisciplinary collaborations have resulted in many groundbreaking innovations both in the research and application. The basis for successful collaborations is the ability to communicate across disciplines: What projects are the others working on? Which techniques and methods are they using? How is data collected, used and stored? In this webinar series, several experts describe their view on computational neuroscience in theory and application, and share experiences they had with interdisciplinary projects. This webinar is open for all interested students and researchers. If you are interested to participate live, please send a short message to smartstart@fz-juelich.de Please note, these lectures will be recorded for subsequent publishing as online lecture material.

Innovation Loans Expression of Interest

Photopharmacology in the spotlight: Spatially selective adenosinergic modulation of hippocampal excitability in the pursuit of therapeutic innovation in temporal lobe epilepsy

FENS Forum 2024